Federal Trade Commission opens investigation into pharmacy benefit managers

The Federal Trade Commission has voted unanimously to launch an inquiry into pharmacy benefit managers, requiring the six largest managers to supply records pertaining to their business practices, according to an agency press release.The FTC will send orders to CVS Caremark, Express Scripts Inc., OptumRx Inc., Humana Inc., Prime Therapeutics LLC and MedImpact Healthcare Systems Inc. and will examine the “impact of vertically integrated pharmacy benefit managers on the affordability and accessibility of prescription drugs,” the agency said.“Although many people have neverRead More

Generated by Feedzy